Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Hu...Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Huanglian Jiedu Decoction were retrieved through TCMSP,and the genes were standardized through Uniprot database.Acquire disease targets related to coronary heart disease and diabetes in OMIM and GeneCards databases.The network diagram of"drug-component-target-disease"is constructed by using the software of cytopscape 3.7.2,the PPI network diagram of protein interaction is constructed by using STRING database,and the network diagram of"drug-disease"core target is constructed by using the software of cytopscape 3.7.2.DAVID's online database platform was used to analyze GO biological process and KEGG pathway enrichment of common targets of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes.Results:103 active ingredients of Huanglian Jiedu Decoction were retrieved,including 140 acting targets,5342 coronary heart disease targets,114 diabetes targets,and 14 common intersection targets of drugs and diseases,involving AR,PPARG,TNF,IL6,CCL2,VEGFA,PON1,etc.The GO biological process analysis results in 98 biological processes,10 cell components and 10 molecular functions.Among them are positive regulation of gene expression,positive regulation of nitric oxide biosynthesis process,Extracellular space,cytokine activity,steroid hormone receptor activity and other biological processes;The enrichment analysis of KEGG pathway yielded 20 signal pathways(P≤0.05).It mainly involves Malaria,cancer in cancer,HIF-1 signaling pathway,TNF signaling pathway,NOD-like receptor signaling pathway,PI3K-Akt signaling pathway,etc.Conclusion:Huanglian Jiedu Decoction"treats different diseases at the same time"coronary heart disease and type 2 diabetes have the characteristics of multiple components,multiple targets and multiple pathways,which provide theoretical basis for Huanglian Jiedu Decoction to treat coronary heart disease and type 2 diabetes in clinic,but the key targets and pathways of Huanglian Jiedu Decoction to treat diseases still need further experimental verification.展开更多
目的:利用网络药理学方法探讨人参四物汤治疗冠状动脉粥样硬化性心脏病(简称冠心病)的作用机制。方法:通过中药系统药理学数据库与分析平台(TCMSP)网络数据库对人参四物汤的有效成分及作用靶点进行挖掘和筛选,利用Uniprot蛋白质数据库...目的:利用网络药理学方法探讨人参四物汤治疗冠状动脉粥样硬化性心脏病(简称冠心病)的作用机制。方法:通过中药系统药理学数据库与分析平台(TCMSP)网络数据库对人参四物汤的有效成分及作用靶点进行挖掘和筛选,利用Uniprot蛋白质数据库寻找蛋白质靶点所对应的人类基因,同时以“coronary heart disease”为关键词挖掘Gene Cards、TTD、DRUGBANK数据库中冠心病相关作用靶点,利用微生信在线数据分析作图网站制作韦恩图,并将所得交集靶点导入Cytoscape 3.7.2,构建“药物-有效成分-靶点-疾病”网络。基于STRING数据库,构建蛋白质-蛋白质相互作用网络模型;再利用Bisogenet进行拓扑分析,筛选出关键靶点;最后利用Metascape数据库对药物-疾病交集靶点进行生物功能和通路的富集分析。结果:人参四物汤治疗冠心病的核心活性成分为山柰酚、豆甾醇、β-谷甾醇等。核心靶点为核磷脂素1(NPM1)、异质性胞核核糖核蛋白U(HNRNPU)、热休克蛋白A5[Heat Shock Protein Family A(Hsp70)Member 5,HSPA5]、热休克蛋白A8[Heat Shock Protein Family A(Hsp70)Member 8,HSPA8]、人真核翻译延伸因子1a1(EEF1A1)、异质性胞核核糖核蛋白P2(FUS)、核糖体蛋白S27A(RPS27A)、反式激活应答DNA结合蛋白(TARDBP)等。关键通路为脂质与动脉粥样硬化、血流剪切力与动脉粥样硬化、白细胞介素-17(Interleukin-17,IL-17)信号通路等。结论:人参四物汤通过多成分、多靶点、多通路治疗冠心病,为临床冠心病的治疗提供了新的思路。展开更多
目的:运用网络药理学和分子对接技术探析养心活血通脉汤治疗稳定性冠心病的作用机制。方法:应用TCMSP、Herb、TCMID平台检索养心活血通脉汤成分及作用靶点;经GeneCards、OMIM、DisGeNET平台获取稳定性冠心病靶点;运用Cytoscape 3.9.1建...目的:运用网络药理学和分子对接技术探析养心活血通脉汤治疗稳定性冠心病的作用机制。方法:应用TCMSP、Herb、TCMID平台检索养心活血通脉汤成分及作用靶点;经GeneCards、OMIM、DisGeNET平台获取稳定性冠心病靶点;运用Cytoscape 3.9.1建立“药物-活性成分-靶点”网络及蛋白质-蛋白质相互作用(PPI)网络,筛选核心靶点。由Metascape平台进行基因本体(GO)功能和京都基因与基因组百科全书(KEGG)通路富集分析。利用Auto Dock Tools软件进行有效成分与和核心靶点分子对接。结果:养心活血通脉汤治疗稳定性冠心病主要成分为槲皮素、山柰酚、β-谷甾醇、芒柄花黄素、黄芩素、丹参酮ⅡA,关键靶点为肿瘤坏死因子(TNF)、白细胞介素-6(IL-6)、丝氨酸/苏氨酸激酶1(AKT1)、白细胞介素-1β(IL-1β)、血管内皮生长因子(VEGFA),关键通路为脂质和动脉粥样硬化(Lipid and atherosclerosis)、磷脂酰肌醇3激酶-丝氨酸/苏氨酸蛋白激酶1信号通路(PI3K-Akt信号通路)、肿瘤坏死因子信号通路(TNF信号通路)、丝裂原活化蛋白激酶信号通路(MAPK信号通路)、糖基化终产物/受体信号通路(AGE-RAGE信号通路)等。分子对接结果显示各有效成分与各核心靶点结合活性较好。结论:养心活血通脉汤治疗稳定性冠心病作用机制主要为降脂、抗动脉粥样硬化、抗炎、抗心肌损伤。展开更多
基金National Major Specialized Science and Technology Project for New Drugs Development(No.2017ZX09301003)。
文摘Objective:To explore the common mechanism of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes by network pharmacology.Methods:All chemical components and targets of the four drugs in Huanglian Jiedu Decoction were retrieved through TCMSP,and the genes were standardized through Uniprot database.Acquire disease targets related to coronary heart disease and diabetes in OMIM and GeneCards databases.The network diagram of"drug-component-target-disease"is constructed by using the software of cytopscape 3.7.2,the PPI network diagram of protein interaction is constructed by using STRING database,and the network diagram of"drug-disease"core target is constructed by using the software of cytopscape 3.7.2.DAVID's online database platform was used to analyze GO biological process and KEGG pathway enrichment of common targets of Huanglian Jiedu Decoction in treating coronary heart disease and type 2 diabetes.Results:103 active ingredients of Huanglian Jiedu Decoction were retrieved,including 140 acting targets,5342 coronary heart disease targets,114 diabetes targets,and 14 common intersection targets of drugs and diseases,involving AR,PPARG,TNF,IL6,CCL2,VEGFA,PON1,etc.The GO biological process analysis results in 98 biological processes,10 cell components and 10 molecular functions.Among them are positive regulation of gene expression,positive regulation of nitric oxide biosynthesis process,Extracellular space,cytokine activity,steroid hormone receptor activity and other biological processes;The enrichment analysis of KEGG pathway yielded 20 signal pathways(P≤0.05).It mainly involves Malaria,cancer in cancer,HIF-1 signaling pathway,TNF signaling pathway,NOD-like receptor signaling pathway,PI3K-Akt signaling pathway,etc.Conclusion:Huanglian Jiedu Decoction"treats different diseases at the same time"coronary heart disease and type 2 diabetes have the characteristics of multiple components,multiple targets and multiple pathways,which provide theoretical basis for Huanglian Jiedu Decoction to treat coronary heart disease and type 2 diabetes in clinic,but the key targets and pathways of Huanglian Jiedu Decoction to treat diseases still need further experimental verification.
文摘目的:利用网络药理学方法探讨人参四物汤治疗冠状动脉粥样硬化性心脏病(简称冠心病)的作用机制。方法:通过中药系统药理学数据库与分析平台(TCMSP)网络数据库对人参四物汤的有效成分及作用靶点进行挖掘和筛选,利用Uniprot蛋白质数据库寻找蛋白质靶点所对应的人类基因,同时以“coronary heart disease”为关键词挖掘Gene Cards、TTD、DRUGBANK数据库中冠心病相关作用靶点,利用微生信在线数据分析作图网站制作韦恩图,并将所得交集靶点导入Cytoscape 3.7.2,构建“药物-有效成分-靶点-疾病”网络。基于STRING数据库,构建蛋白质-蛋白质相互作用网络模型;再利用Bisogenet进行拓扑分析,筛选出关键靶点;最后利用Metascape数据库对药物-疾病交集靶点进行生物功能和通路的富集分析。结果:人参四物汤治疗冠心病的核心活性成分为山柰酚、豆甾醇、β-谷甾醇等。核心靶点为核磷脂素1(NPM1)、异质性胞核核糖核蛋白U(HNRNPU)、热休克蛋白A5[Heat Shock Protein Family A(Hsp70)Member 5,HSPA5]、热休克蛋白A8[Heat Shock Protein Family A(Hsp70)Member 8,HSPA8]、人真核翻译延伸因子1a1(EEF1A1)、异质性胞核核糖核蛋白P2(FUS)、核糖体蛋白S27A(RPS27A)、反式激活应答DNA结合蛋白(TARDBP)等。关键通路为脂质与动脉粥样硬化、血流剪切力与动脉粥样硬化、白细胞介素-17(Interleukin-17,IL-17)信号通路等。结论:人参四物汤通过多成分、多靶点、多通路治疗冠心病,为临床冠心病的治疗提供了新的思路。
文摘目的:运用网络药理学和分子对接技术探析养心活血通脉汤治疗稳定性冠心病的作用机制。方法:应用TCMSP、Herb、TCMID平台检索养心活血通脉汤成分及作用靶点;经GeneCards、OMIM、DisGeNET平台获取稳定性冠心病靶点;运用Cytoscape 3.9.1建立“药物-活性成分-靶点”网络及蛋白质-蛋白质相互作用(PPI)网络,筛选核心靶点。由Metascape平台进行基因本体(GO)功能和京都基因与基因组百科全书(KEGG)通路富集分析。利用Auto Dock Tools软件进行有效成分与和核心靶点分子对接。结果:养心活血通脉汤治疗稳定性冠心病主要成分为槲皮素、山柰酚、β-谷甾醇、芒柄花黄素、黄芩素、丹参酮ⅡA,关键靶点为肿瘤坏死因子(TNF)、白细胞介素-6(IL-6)、丝氨酸/苏氨酸激酶1(AKT1)、白细胞介素-1β(IL-1β)、血管内皮生长因子(VEGFA),关键通路为脂质和动脉粥样硬化(Lipid and atherosclerosis)、磷脂酰肌醇3激酶-丝氨酸/苏氨酸蛋白激酶1信号通路(PI3K-Akt信号通路)、肿瘤坏死因子信号通路(TNF信号通路)、丝裂原活化蛋白激酶信号通路(MAPK信号通路)、糖基化终产物/受体信号通路(AGE-RAGE信号通路)等。分子对接结果显示各有效成分与各核心靶点结合活性较好。结论:养心活血通脉汤治疗稳定性冠心病作用机制主要为降脂、抗动脉粥样硬化、抗炎、抗心肌损伤。
